Published on 7 May 2024 on Simply Wall St. via Yahoo Finance
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even
We feel now is a pretty good time to analyse Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) business as it appears the company may be on the cusp of a considerable accomplishment. Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The US$96m market-cap company announced a latest loss of US$936k on 31 December 2023 for its most recent financial year result. The most pressing concern for investors is Eton Pharmaceuticals' path to profitability – when will it breakeven? In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.
See our latest analysis for Eton Pharmaceuticals